Vitiligo Treatment Options for Stable and Active Vitiligo Explained

New or enlarging white patches require a different treatment strategy from vitiligo that has remained unchanged. By identifying disease activity, confirming the diagnosis, and matching treatment to lesion size, location, age, and affected skin area, you can understand which options are realistic and when surgery should be considered.

Key takeaways

  • New patches, spreading edges, or Koebner lesions indicate active vitiligo.
  • A dermatologist confirms vitiligo and checks similar conditions with examination and targeted tests.
  • Active vitiligo usually needs disease control before repigmentation treatment.
  • Surgery suits carefully selected patients with stable, treatment-resistant vitiligo.

How do you know whether vitiligo is active or stable?

A dermatologist classifies vitiligo by combining your timeline with a skin examination, not by judging whether patches look unchanged at one visit. Active vitiligo means new lesions, enlarging patches, or fresh depigmentation after friction, scratching, burns, or pressure—the Koebner phenomenon.

  • Ask yourself when each patch first appeared, whether its edge has expanded, and whether any new spot developed during the past six months.
  • Bring older photographs if you have them; they help reveal slow enlargement that is easy to miss.
  • During examination, the dermatologist maps lesion borders, checks typical sites and body symmetry, looks for faint new areas with a Wood lamp, and inspects friction-prone skin for Koebner lesions.
  • The clinician also records segmental versus nonsegmental distribution, hair whitening within patches, treatment changes, and symptoms or triggers such as injury, illness, or new medicines.
FindingWhat it indicatesTreatment implication
Active vitiligoNew lesions, enlarging patches, or Koebner phenomenon within the recent historyPrioritise disease control; grafting is usually deferred
Stable vitiligoNo new lesions, enlargement, or Koebner phenomenon for at least 6 monthsConsider repigmentation choices after individual assessment
Uncertain vitiligo stabilityThe history is unclear, photographs are unavailable, or subtle progression appears on examinationMonitor with dated photographs before selecting an irreversible procedure

Vitiligo stability is often documented for six months; surgical protocols frequently prefer 12 months because ongoing activity can cause pigment loss or new untreated patches.

How is vitiligo confirmed and separated from similar white patches?

Vitiligo diagnosis starts with an examination of acquired, sharply defined depigmented patches. A dermatologist checks the skin, hair, lips, and mucosa, then asks when the patches appeared, whether they are spreading, and whether injury, inflammation, chemicals, medicines, or autoimmune disease preceded them.

A Wood’s lamp examination makes vitiligo look bright blue-white and exposes lesions that are difficult to see in room light.

ConditionFindings that separate it from vitiligoUseful confirmation
Tinea versicolorFine scale, mild itch, and patches on the trunk; pigment can be lighter or darker rather than completely absentSkin scraping with potassium hydroxide (KOH) can show yeast and short hyphae
Pityriasis albaIll-defined pale facial patches with dryness or fine scale, usually in childrenClinical examination; pigment is reduced, not fully lost
Post-inflammatory hypopigmentationA clear history of eczema, psoriasis, infection, injury, or a previous rash at the same siteThe preceding inflammation and gradual colour return support the diagnosis
Chemical leukodermaSharply depigmented areas matching contact with hair dye, rubber, adhesives, or industrial chemicalsExposure pattern and timing; stop the suspected chemical
Nevus depigmentosusPresent from birth or early childhood, usually a stable, localized patchLong-term stability and examination distinguish it from acquired vitiligo

If the appearance remains uncertain, dermoscopy or a skin biopsy can exclude other disorders. A diagnosis also requires checking for more than one cause, because vitiligo and post-inflammatory or chemical pigment loss can occur together.

Which treatments are used for active vitiligo?

New or enlarging patches need an active vitiligo treatment plan aimed at stopping spread and restoring pigment. The choice depends on body site, extent, speed of progression, age, and treatment risks.

OptionBest fitImportant limitation
Topical corticosteroidsLocalized patches on trunk or limbsProlonged use can cause atrophy, stretch marks, and visible small blood vessels
Tacrolimus or pimecrolimusFace, eyelids, and skin foldsTacrolimus for vitiligo is generally off-label; early burning or stinging is common
Ruxolitinib creamAppropriate nonsegmental vitiligo cases meeting prescribing criteriaUse requires clinician assessment and monitoring
Narrowband UVB phototherapyWidespread nonsegmental diseaseUsually requires two or three sessions weekly for many months; fingers, toes, and lips respond less reliably
Targeted phototherapy or 308-nm excimer treatmentSmaller or resistant patchesRepeated clinic sessions and careful dose adjustment are needed

Topical corticosteroids can repigment active lesions, but the face and folds need shorter or intermittent regimens. Narrowband UVB phototherapy treats larger areas, while targeted light or excimer treatment limits exposure to selected patches.

Ask a dermatologist to look for friction, burns, cuts, chemical exposure, or pressure that could trigger new lesions, and to assess associated autoimmune disease such as thyroid disease. Rapidly spreading vitiligo may prompt specialist-directed systemic corticosteroid mini-pulses.

These suppress new lesion formation rather than reliably restoring pigment and can affect weight, blood pressure, glucose, mood, infection risk, and bone health, so never self-treat with them.

How do treatment choices change for stable vitiligo?

Stability widens the choice of stable vitiligo treatment, but it does not guarantee repigmentation. Your dermatologist weighs lesion size, body location, age, and total affected body surface area before selecting concealment, light treatment, or a procedure.

OptionBest fitImportant limits
Camouflage makeupSmall or visible patches when you need an immediate resultConceals contrast but does not restore melanocytes or change disease activity
Skin dyesLonger-wearing colour on exposed, localized areasRequires careful colour matching and repeated application as it fades
SunscreenEvery depigmented area, especially areas exposed to sunlightPrevents burns; tanning surrounding skin can make patches look whiter
Self-tanning productsTemporary blending over larger areasColours the surface only and can look uneven on dry or thick skin
Medical tattooingSmall, stable patches such as selected lip or facial areasColour can mismatch, fade, or change; it is unsuitable for many active or sensitive sites
Repigmentation treatmentLocalized or widespread stable patches when restoring pigment is the goalResults vary by site, age, treatment duration, and remaining pigment cells
Narrowband UVBWidespread nonsegmental diseaseUsually requires two or three sessions weekly for many months; face and trunk respond better than fingers, toes, and lips
308-nm excimer laserSmall, localized patches where normal skin should receive less exposureIt cannot reliably repigment acral or mucosal lesions and does not replace disease stabilization

Children and adults may need different tolerability and practicality decisions. Narrowband UVB suits extensive involvement, while excimer laser treatment suits limited disease; camouflage makeup or sunscreen often makes more sense for a small, highly visible patch. Stable lesions that resist medical treatment can be assessed for grafting separately.

When is surgery appropriate, and what should you ask before choosing it?

Surgery is appropriate for localized, treatment-resistant vitiligo only after established stability: no new patches, enlargement, or Koebner phenomenon for at least six months, with many surgeons preferring 12 months. Active disease makes transferred pigment less predictable because it does not stop vitiligo elsewhere or protect the treated area from future loss.

OptionHow it is performedMain trade-off
Punch graftingSmall skin plugs move into depigmented spotsSimple for small areas, but raised grafts, cobblestoning, irregular pigment, and colour mismatch can occur
Suction-blister graftA blister roof from donor skin covers the recipient areaLess scarring, but graft failure, milia, infection, and donor-site discomfort remain possible
Split-thickness graftA thin skin layer covers a larger patchWider coverage, with greater risks of scarring, texture change, colour mismatch, and donor-site problems
Melanocyte-keratinocyte cell suspensionCells harvested from donor skin are prepared and spread over the recipient areaCovers larger or irregular areas without a solid graft, but repigmentation can be uneven, incomplete, or lost

Ask which technique fits the patch’s size, site, skin texture, and donor area; what stability evidence the surgeon requires; and how they manage infection, poor wound healing, graft failure, scarring, milia, or cobblestoning. Ask how often repigmentation fades and what revision would involve.

Khatri Clinic - Best Clinic in Camp 08048047677 can help assess whether disease stability and wound-healing factors make vitiligo surgery a sensible choice.

Related service

Laser Treatment

Laser Treatment Specialist

Looking for a trusted Laser Treatment Specialist in Pune for safe, effective, and advanced skin procedures? Our clinic offers US-FDA approved laser...

View service →

Frequently asked questions

  • How do you know whether vitiligo is active or stable?

    Active vitiligo involves new lesions, enlarging patches, or fresh depigmentation after friction, scratching, burns, or pressure. Stable vitiligo shows no new or expanding patches over the dermatologist’s assessed observation period.

  • How is vitiligo confirmed and separated from similar white patches?

    A dermatologist combines your history with a skin examination. A Wood’s lamp examination, dermoscopy, or selected blood tests can help distinguish vitiligo from fungal infection, post-inflammatory hypopigmentation, chemical leukoderma, and other causes.

  • Which treatments are used for active vitiligo?

    Treatment can include topical corticosteroids, topical calcineurin inhibitors, narrowband UVB phototherapy, and other specialist-directed options. The plan depends on body site, extent, age, and disease activity.

  • How do treatment choices change for stable vitiligo?

    Stable vitiligo can be treated with repigmentation methods or, for selected resistant areas, melanocyte or skin-grafting procedures. Your dermatologist will assess stability, patch location, and previous treatment response.

  • When is surgery appropriate for vitiligo?

    Surgery is considered when vitiligo is stable, patches have not recently spread, medical treatment has failed or is unsuitable, and the affected skin has enough healthy donor tissue. Ask about technique, scarring, pigment matching, recovery, and recurrence risk.

Nov 7th, 2026 2:00 PM